These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7487974)

  • 1. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).
    Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y
    Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8.
    Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y
    Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
    Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
    Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K; Sakota E; Kozu T
    Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia.
    Sacchi N; Schiaffonati L; Magnani I; Pappalardo C; Hughes AJ; Darfler M; Hoogeveen AT
    Oncogene; 1996 Jan; 12(2):437-44. PubMed ID: 8570222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
    Erickson PF; Robinson M; Owens G; Drabkin HA
    Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
    Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA.
    Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
    J Cancer Res Clin Oncol; 1996; 122(4):254-6. PubMed ID: 8601580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of AML1 and ETO Transcripts in hematopoietic cells.
    Era T; Asou N; Yamaguchi K; Yamasaki H; Kamada N; Nishikawa S; Takatsuki K
    Leukemia; 1995 Oct; 9 Suppl 1():S26-8. PubMed ID: 7475308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
    Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
    Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes.
    Szyrach M; Münchberg FE; Riehle H; Nordheim A; Krauter J; Nagel S; Heil G; Heidenreich O
    Eur J Biochem; 2001 Jun; 268(12):3550-7. PubMed ID: 11422386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rearrangements and fusion gene of AML1 and MTG8 in acute myeloid leukemia M2b].
    Wang J; Xiao Z; Hao Y
    Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):399-402, 445. PubMed ID: 7553157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
    Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
    Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript].
    Kazama H; Aoyama M; Sameshima Y; Teramura M; Masuda M; Motoji T; Okada M; Mizoguchi H
    Rinsho Ketsueki; 1996 Nov; 37(11):1297-302. PubMed ID: 8960665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of MTG8 in leukemogenesis.
    Kozu T; Komori A; Sueoka E; Fujiki H; Kaneko Y; Matsui T; Uehara T; Seino Y; Ishii M
    Leukemia; 1997 Apr; 11 Suppl 3():297-8. PubMed ID: 9209371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.